 | Up a level |
Ercolano, Giuseppe; Gomez-Cadena, Alejandra; Dumauthioz, Nina; Vanoni, Giulia; Kreutzfeldt, Mario; Wyss, Tania; Michalik, Liliane; Loyon, Romain; Ianaro, Angela; Ho, Ping-Chih; Borg, Christophe; Kopf, Manfred; Merkler, Doron; Krebs, Philippe; Romero, Pedro; Trabanelli, Sara; Jandus, Camilla (2021). PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions. Nature Communications, 12(1), p. 2538. Springer Nature 10.1038/s41467-021-22764-2
Pich, Christine; Meylan, Patrick; Mastelic-Gavillet, Beatris; Nguyen, Thanh Nhan; Loyon, Romain; Trang, Bao Khanh; Moser, Hélène; Moret, Catherine; Göpfert, Christine; Hafner, Jürg; Levesque, Mitchell P; Romero, Pedro; Jandus, Camilla; Michalik, Liliane (2018). Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth. Cancer research, 78(22), pp. 6447-6461. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-18-0912
Rieusset, Jennifer; Seydoux, Josiane; Anghel, Silvia I; Escher, Pascal; Michalik, Liliane; Soon Tan, Nguan; Metzger, Daniel; Chambon, Pierre; Wahli, Walter; Desvergne, Béatrice (2004). Altered growth in male peroxisome proliferator-activated receptor gamma (PPARgamma) heterozygous mice: involvement of PPARgamma in a negative feedback regulation of growth hormone action. Molecular endocrinology, 18(10), pp. 2363-2377. Endocrine Society 10.1210/me.2003-0325
Rieusset, Jennifer; Touri, Fethi; Michalik, Liliane; Escher, Pascal; Desvergne, Béatrice; Niesor, Eric; Wahli, Walter (2002). A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. Molecular endocrinology, 16(11), pp. 2628-2644. Endocrine Society 10.1210/me.2002-0036
